Opening book details…
About this nonfiction
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial by Rothenberg, Marc E (author);Dellon, Evan S (author);Collins, Margaret H (author);Hirano, Ikuo (author);Chehade, Mirna (author);Bredenoord, Albert J (author);Lucendo, Alfredo J (author);Spergel, Jonathan M (author);Sun, Xian (author);Hamilton, Jennifer D (author);Mortensen, Eric (author);Laws, Elizabeth (author);Maloney, Jennifer (author);Mannent, Leda P (author);McCann, Eilish (author);Liu, Xia (author);Glotfelty, Lila (author);Shabbir, Arsalan (author) is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Rothenberg, Marc E (author);Dellon, Evan S (author);Collins, Margaret H (author);Hirano, Ikuo (author);Chehade, Mirna (author);Bredenoord, Albert J (author);Lucendo, Alfredo J (author);Spergel, Jonathan M (author);Sun, Xian (author);Hamilton, Jennifer D (author);Mortensen, Eric (author);Laws, Elizabeth (author);Maloney, Jennifer (author);Mannent, Leda P (author);McCann, Eilish (author);Liu, Xia (author);Glotfelty, Lila (author);Shabbir, Arsalan (author)
- Publisher
- Elsevier BV
- Published
- 2023
- Language
- EN
- Category
- nonfiction
More by Rothenberg, Marc E (author);Dellon, Evan S (author);Collins, Margaret H (author);Hirano, Ikuo (author);Chehade, Mirna (author);Bredenoord, Albert J (author);Lucendo, Alfredo J (author);Spergel, Jonathan M (author);Sun, Xian (author);Hamilton, Jennifer D (author);Mortensen, Eric (author);Laws, Elizabeth (author);Maloney, Jennifer (author);Mannent, Leda P (author);McCann, Eilish (author);Liu, Xia (author);Glotfelty, Lila (author);Shabbir, Arsalan (author)
Similar books
- Safety and Efficacy of Arimoclomol in Patients with Early Amyotrophic Lateral Sclerosis (ORARIALS-01): a Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Trial — Benatar, Michael; Hansen, Thomas; Rom, Dror; Geist, Marie A; Blaettler, Thomas; Camu, William; Kuzma-Kozakiewicz, Magdalena; van den Berg, Leonard H; Morales, Raul Juntas; Chio, Adriano; Andersen, Peter M; Pradat, Pierre-Francois; Lange, Dale; Van Damme, Philip; Mora, Gabriele; Grudniak, Mariusz; Elliott, Matthew; Petri, Susanne; Olney, Nicholas; Ladha, Shafeeq; Goyal, Namita A; Meyer, Thomas; Hanna, Michael G; Quinn, Colin; Genge, Angela; Zinman, Lorne; Jabari, Duaa; Shoesmith, Christen; Ludolph, Albert C; Neuwirth, Christoph; Nations, Sharon; Shefner, Jeremy M; Turner, Martin R; Wuu, Joanne; Bennett, Richard; Dang, Hoang; Sundgreen, Claus; Granit, Volkan; Steele, Julie; Levy, Wendy; Paredes, Maria Elena; Hernandez, Jessica; Bilsker, Martin; Szacka, Katarzyna; Ronert, Adam; Jablońska, Dorota; Łuczak, Alina Zuzanna; Chaverri, Delia; Janse van Mantgem, Mark R; Bunte, Tommy M; Broere, Bianca; de Fockert, Arianne; Sanchez-Tejerina, Daniel; Landabaso, Carmen; Calvo, Andrea; Moglia, Cristina; Manera, Umberto; Canosa, Antonio; Vasta, Rosario; Salamone, Paolina; Fuda, Giuseppe; DeMarco, Giovanni; Casale, Federico; ME Forsberg, Karin; Winroth, Ivar; Almgren Stenberg, Erica; Holmgren, Monica; Amador, Maria del Mar; Lenglet, Timothee; Querin, Giorgia; Coudoin, Sylvie; Pavlakis, Pantelis; Holzberg, Shara; Sideri, Riccardo; Marinou, Kalliopi; Czarnecki, Maciej; Ługiewicz, Renata (a (2024)
- Safety and Efficacy of Teriflunomide in Paediatric Multiple Sclerosis (TERIKIDS): a Multicentre, Double-blind, Phase 3, Randomised, Placebo-controlled Trial — Chitnis, Tanuja; Banwell, Brenda; Kappos, Ludwig; Arnold, Douglas L; Gücüyener, Kivilcim; Deiva, Kumaran; Skripchenko, Natalia; Cui, Li-Ying; Saubadu, Stephane; Hu, Wenruo; Benamor, Myriam; Le-Halpere, Annaig; Truffinet, Philippe; Tardieu, Marc; Dubois, Benedicte; Verhelst, Helene; Bojinova-Tchamova, Veneta; Mah, Jean; Cui, Li-Ying; Fang, Hao, Yunpeng; Jiang, Li; Ling; Mao, Ding'An; Qiu, Wei; Tan, Guojun; Wu, Ye; Zhang, Meini; Zhou, Hongyu; Zhou, Shuizhen; Gross-Paju, Katrin; Cheuret, Emmanuel; Deiva, Kumaran; Edan, Giles; Vukusic, Sandra; Chrousos, George; Zafeiriou, Dimitrios; Achiron, Anat; Vaknin-Dembinsky, Adi; Yamout, Bassem; Laurynaitiene, Jurate; Vaiciene-Magistris, Nerija; Bojkovski, Vladimir; Trajkova, Vesna; Chaouki, Sana; Kissani, Najib; Neuteboom, Rinze; Palavra, Filipe; Belova, Anna; Boyko, Alexey; Evdoshenko, Evgeny; Kairbekova, Ekaterina; Malkova, Nadezhda; Shumilina, Maria; Skripchenko, Natalya; Nikolic, Dimitrije; Meca-Lallana, Jose; Triki, Chahnez Charfi; Chokri, Mhiri; Gouider, Riadh; Anlar, Banu; Gücüyener, Kivilcim; Hiz, Ayse Semra; Idiman, Egemen; Turkoglu, Recai; Yapici, Zuhal; Yilmaz, Unsal; Tantsura, Lyudmyla; Voloshyna, Nataliia; Lim, Ming; Wassmer, Evangeline; Cascione, Mark; Chitnis, Tanuja; LaGanke, Christopher; Rathke, Kevin; Scagnelli, John (2021)
- Efficacy, safety, and target engagement of dazukibart, an IFNÃŽÂ2 specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial — Prof David Fiorentino MD PhD & Aaron R Mangold MD & Prof Victoria P Werth MD & Prof Lisa Christopher-Stine MD & Alisa Femia MD & Myron Chu DO & Prof Amy C M Musiek MD & Jason C Sluzevich MD & Lauren V Graham MD & Anthony P Fernandez MD & Prof Rohit... (2025)
- Safety and Efficacy of Nipocalimab in Adults with Generalised Myasthenia Gravis (Vivacity-MG3): a Phase 3, Randomised, Double-blind, Placebo-controlled Study — Antozzi, Carlo; Vu, Tuan; Ramchandren, Sindhu; Nowak, Richard J; Farmakidis, Constantine; Bril, Vera; De Bleecker, Jan; Yang, Huan; Minks, Eduard; Park, Jin-Sung; Grudniak, Mariusz; Smilowski, Marek; Sevilla, Teresa; Hoffmann, Sarah; Sivakumar, Kumaraswamy; Suzuki, Yasushi; Youssef, Eriene; Sanga, Panna; Karcher, Keith; Zhu, Yaowei; Sheehan, John J; Sun, Hong (2025)
- Efficacy and Safety of Selumetinib in Adults with Neurofibromatosis Type 1 and Symptomatic, Inoperable Plexiform Neurofibromas (KOMET): a Multicentre, International, Randomised, Placebo-controlled, Parallel, Double-blind, Phase 3 Study — Chen, Alice P; Coyne, Geraldine O'Sullivan; Wolters, Pamela L; Martin, Staci; Farschtschi, Said; Blanco, Ignacio; Chen, Zhongping; Darrigo, Luiz Guilherme; Eoli, Marica; Whittle, James R; Nishida, Yoshihiro; Lamarca, Rosa; de la Rosa Rodriguez, Randolph; Adeyemi, Ayo; Herrero, Idoia; Llorente, Nereida; Diede, Scott J; Dombi, Eva; Wolkenstein, Pierre; Lee, Alexander; Mastronuzzi, Angela; Swampillai, Angela; Bokhyan, Beniamin; Van Tine, Brian; Barnett-Tapia, Carolina; Matthies, Cordula; Shuhaiber, Hans; Styczynski, Jan; Sepulveda Sanchez, Juan M.; Fertitta, Laura; Severino-Freire, Maëlla; D'Agostino, Maria D.; Dorofeeva, Marina; Schuhmann, Martin; Liu, Pinan; Nakayama, Robert; Perez Pereira, Rodrigo; Perrotta, Silverio; Sonaglio, Viviane; Gao, Xinghua; Berman, Yemima; Zhu, Yicheng; Nobeyama, Yoshimasa (2025)
- Atosiban Versus Placebo for Threatened Preterm Birth (APOSTEL 8): a Multicentre, Randomised Controlled Trial — van der Windt, Larissa I; Klumper, Job; Duijnhoven, Ruben G; Kok, Marjolein; Ris-Stalpers, Carrie; de Boer, Marjon A; van Kaam, Anton H; Pajkrt, Eva; Mol, Ben W; Walker, Kate F; McAuliffe, Fionnuala M; van der Post, Joris A; Roos, Carolien; Oudijk, Martijn A; Schaaf, Jelle M; van Eyck, Jim; Knol, H Marieke; Sueters, Marieke; Scheepers, Liesbeth H C J; van der Ham, David P; van Laar, Judith O E H; van den Akker, Eline S A; Scholten, Ralph R; van Gemund, Nicolette; Vollebregt, Karlijn C; Visser, Harrie; Gordijn, Sanne J; Bekker, Mireille N; Langenveld, Josje (2025)